A Single-Dose,ComparativeBioavailability Study ofTwo Formulations ofErlotinib150mgTabletsunderFastingConditions
Clinical trial NCT04145570 · COMPLETED
Trial details
- NCT number
- NCT04145570
- Sponsor
- Quadras Scientific Solutions
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2008-10-23
- Primary completion
- 2008-11-09
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.